| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-08 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |